Goldman Sachs Reduced Bath & Body Works Inc (BBWI) Price Target

Goldman Sachs maintained its Buy recommendation on Bath & Body Works, Inc. (NYSE:BBWI) shares and reduced its price objective from $44 to $43.

A female customer browsing a variety of body care products in a retail store.

Bath & Body Works, Inc. (NYSE:BBWI)’s strong first-quarter results were probably overshadowed by guidance that fell short of expectations. However, the analyst informs investors in a research note that today’s 6% stock price loss “seems overdone” because the firm’s FY25 EPS forecast is only declining by roughly 3%.

The Ohio-based business profited from U.S. sourcing, with only 10% of items coming from China and 7% from Canada and Mexico, reducing exposure to tariffs amid President Trump’s continued trade uncertainty.

Bath & Body Works, Inc. (NYSE:BBWI)’s CFO Eva Boratto noted the company’s innovative products, such as Easter-themed candles, its robust domestic supply chain, and its ability to appeal to younger consumers through gift packaging and promotions.

While we acknowledge the potential of BBWI to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk.  If you are looking for an AI stock that is more promising than BBWI and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025.

Disclosure. None.